Abstract

Positron emission tomography/computed tomography (PET/CT scan) represents a new molecular imaging modality using physiological tracers to assess a lesion’s metabolic state. [18F]Fluorodeoxyglucose (FDG) PET appears to be very good for...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Clinical and ultrasonographic enthesitis assessment before and after anti-tumor necrosis factor treatment in patients with spondyloarthritis.
Gunay Er ... Ibrahim Asoglu
Turkish journal of physical medicine and rehabilitation | VOL. 70
Gunay Er, et. al.Gunay Er ... Ibrahim Asoglu
01 Mar 2024
Decreased clinical response to adalimumab in ankylosing spondylitis is associated with antibody formation
A Spoorenberg ... M T Nurmohamed
Annals of the Rheumatic Diseases | VOL. 68
A Spoorenberg, et. al.A Spoorenberg ... M T Nurmohamed
12 Oct 2009
Remission in nonradiographic axial spondyloarthritis treated with anti-tumor necrosis factor-α drugs: an Italian multicenter study.
Salvatore D’Angelo ... Olga Addimanda
The Journal of rheumatology | VOL. 42
Salvatore D’Angelo, et. al.Salvatore D’Angelo ... Olga Addimanda
15 Dec 2014
Thyroid Function Tests in Ankylosing Spondylitis Patients on Anti-Tumour Necrosis Factor Treatment
Gulcan Gurer ... Betul Sargin
THE ULUTAS MEDICAL JOURNAL | VOL. 6
Gulcan Gurer, et. al.Gulcan Gurer ... Betul Sargin
01 Jan 2020
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers